Skip to content

Public FDA record

Z-0705-06: Gambro Prisma M100 preset, Part No. 8353486.

Recall record Z-0705-06 for Gambro Renal Products, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0705-06
Company in FDA record
Gambro Renal Products, Inc.
FDA classification date
Apr 5, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

After dialysis machine is disconnected from the patient, blood leakage may occur while unloading the tubing sets from the machine.

Source facts

Action
Recall information was forwarded to all Gambro Sale Organizations. Notification was sent to all US consignees on November 2nd and November 3rd, 2005.
Initiated
2005-10-24
Root cause
Other
Terminated
2012-04-17
Distribution
Nationwide, including VA facilities in AZ, CA, DC, FL, GA, MI, MO, NJ, NY, OH, OR, PA, PR, TX, UT, VA, WI. Military distribution to CA and TX. Foreign distribution to Australia, Canada, Denmark, France, Germany, Hungary, UK.
Recall number
Z-0705-06
Recall status
Terminated
CDRH record ID
43082
FDA classified
2006-04-05
Recall event number
34080

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗